{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:33:51Z","timestamp":1787319231736,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Safety Platform for Emergency Vaccines (SPEAC), under the Special Populations Work Package 5, a Brighton Collaboration project of the Coalition for Epidemic Preparedness (CEPI)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Health"],"DOI":"10.1186\/s12978-025-02008-y","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T07:12:31Z","timestamp":1744701151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Safety, immunogenicity, efficacy, and effectiveness of Lassa fever vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Jamile","family":"Ballivian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel","family":"Berrueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Ciapponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Sambade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Stegelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustina","family":"Mazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Bardach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Brizuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Comand\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Castellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward P. K.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Stergachis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor M.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre M.","family":"Buekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"issue":"4","key":"2008_CR1","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3390\/microorganisms9040772","volume":"9","author":"F Hansen","year":"2021","unstructured":"Hansen F, Jarvis MA, Feldmann H, Rosenke K. Lassa virus treatment options. Microorganisms. 2021;9(4):772. https:\/\/doi.org\/10.3390\/microorganisms9040772.","journal-title":"Microorganisms"},{"key":"2008_CR2","unstructured":"World Health Organization. Lassa fever. 2017 [cited 2024 Jun 1]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/lassa-fever"},{"issue":"11","key":"2008_CR3","doi-asserted-by":"publisher","first-page":"e0006971","DOI":"10.1371\/journal.pntd.0006971","volume":"12","author":"OK Oloniniyi","year":"2018","unstructured":"Oloniniyi OK, Unigwe US, Okada S, Kimura M, Koyano S, Miyazaki Y, et al. Genetic characterization of Lassa virus strains isolated from 2012 to 2016 in southeastern Nigeria. PLoS Negl Trop Dis. 2018;12(11):e0006971. https:\/\/doi.org\/10.1371\/journal.pntd.0006971.","journal-title":"PLoS Negl Trop Dis"},{"issue":"7426","key":"2008_CR4","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","volume":"327","author":"JK Richmond","year":"2003","unstructured":"Richmond JK, Baglole DJ. Lassa fever: epidemiology, clinical features, and social consequences. BMJ. 2003;327(7426):1271\u20135. https:\/\/doi.org\/10.1136\/bmj.327.7426.1271.","journal-title":"BMJ"},{"key":"2008_CR5","doi-asserted-by":"crossref","unstructured":"Wolf T, Ellwanger R, Goetsch U, Wetzstein N, Gottschalk R. Fifty years of imported Lassa fever: a systematic review of primary and secondary cases. J Travel Med. 2020;27(4):taaa035. https:\/\/academic.oup.com\/jtm\/article\/27\/4\/taaa035\/5808990","DOI":"10.1093\/jtm\/taaa035"},{"issue":"3","key":"2008_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/trstmh\/tru009","volume":"108","author":"A Dahmane","year":"2014","unstructured":"Dahmane A, van Griensven J, Van Herp M, Van den Bergh R, Nzomukunda Y, Prior J, et al. Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone. Trans R Soc Trop Med Hyg. 2014;108(3):126\u201332. https:\/\/doi.org\/10.1093\/trstmh\/tru009.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"2008_CR7","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3201\/eid2506.181035","volume":"25","author":"EA Ilori","year":"2019","unstructured":"Ilori EA, Furuse Y, Ipadeola OB, Dan-Nwafor CC, Abubakar A, Womi-Eteng OE, et al. Epidemiologic and clinical features of Lassa fever outbreak in Nigeria, January 1\u2013May 6, 2018. Emerg Infect Dis. 2019;25(6):1066\u201374. https:\/\/doi.org\/10.3201\/eid2506.181035.","journal-title":"Emerg Infect Dis"},{"key":"2008_CR8","unstructured":"Ogbu O, Ajuluchukwu E, Uneke CJ. Lassa fever in West African sub-region: an overview. J Vector Borne Dis. 2007;44(1):1\u201311. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17378212"},{"key":"2008_CR9","unstructured":"Centers for Disease Control and Prevention. Lassa Fever. 2022 [cited 2024 Jun 1]. https:\/\/www.cdc.gov\/vhf\/lassa\/index.html"},{"issue":"5","key":"2008_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/jamapediatrics.2017.5223","volume":"172","author":"D Greenky","year":"2018","unstructured":"Greenky D, Knust B, Dziuban EJ. What pediatricians should know about lassa virus. JAMA Pediatr. 2018;172(5):407\u20138. https:\/\/doi.org\/10.1001\/jamapediatrics.2017.5223.","journal-title":"JAMA Pediatr"},{"issue":"15","key":"2008_CR11","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.1128\/jvi.74.15.6992-7004.2000","volume":"74","author":"MD Bowen","year":"2000","unstructured":"Bowen MD, Rollin PE, Ksiazek TG, Hustad HL, Bausch DG, Demby AH, et al. Genetic diversity among Lassa virus strains. J Virol. 2000;74(15):6992\u20137004. https:\/\/doi.org\/10.1128\/jvi.74.15.6992-7004.2000.","journal-title":"J Virol"},{"key":"2008_CR12","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3389\/fmicb.2015.01037","volume":"6","author":"JT Manning","year":"2015","unstructured":"Manning JT, Forrester N, Paessler S. Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage. Front Microbiol. 2015;6:1037. https:\/\/doi.org\/10.3389\/fmicb.2015.01037.","journal-title":"Front Microbiol"},{"issue":"3","key":"2008_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3201\/eid2403.171905","volume":"24","author":"SLM Whitmer","year":"2018","unstructured":"Whitmer SLM, Strecker T, Cadar D, Dienes H-P, Faber K, Patel K, et al. New lineage of Lassa virus, Togo, 2016. Emerg Infect Dis. 2018;24(3):599\u2013602. https:\/\/doi.org\/10.3201\/eid2403.171905.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"2008_CR14","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.idc.2019.08.002","volume":"33","author":"DA Asogun","year":"2019","unstructured":"Asogun DA, G\u00fcnther S, Akpede GO, Ihekweazu C, Zumla A. Lassa fever: epidemiology, clinical features, diagnosis, management and prevention. Infect Dis Clin North Am. 2019;33(4):933\u201351. https:\/\/doi.org\/10.1016\/j.idc.2019.08.002.","journal-title":"Infect Dis Clin North Am"},{"key":"2008_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/82_2022_261","volume":"440","author":"LI Melnik","year":"2023","unstructured":"Melnik LI. Lassa virus countermeasures. Curr Top Microbiol Immunol. 2023;440:111\u201345. https:\/\/doi.org\/10.1007\/82_2022_261.","journal-title":"Curr Top Microbiol Immunol"},{"key":"2008_CR16","unstructured":"World Health Organization. Lassa fever research and development (R&D) Roadmap. 2019 [cited 2024 Jun 1]. https:\/\/cdn.who.int\/media\/docs\/default-source\/blue-print\/lassafever_rdblueprint_roadmap_advanceddraftjan2019.pdf?sfvrsn=dc00b058_3&download=true"},{"issue":"5","key":"2008_CR17","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/inthealth\/ihac076","volume":"15","author":"D Simons","year":"2023","unstructured":"Simons D. Lassa fever cases suffer from severe underreporting based on reported fatalities. Int Health. 2023;15(5):608\u201310. https:\/\/doi.org\/10.1093\/inthealth\/ihac076.","journal-title":"Int Health"},{"key":"2008_CR18","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.2147\/DDDT.S147276","volume":"12","author":"BM Warner","year":"2018","unstructured":"Warner BM, Safronetz D, Stein DR. Current research for a vaccine against Lassa hemorrhagic fever virus. Drug Des Devel Ther. 2018;12:2519\u201327. https:\/\/doi.org\/10.2147\/DDDT.S147276.","journal-title":"Drug Des Devel Ther"},{"key":"2008_CR19","unstructured":"Nigeria Centre for Disease Control and Prevention. An update of Lassa fever outbreak in Nigeria for week 11."},{"key":"2008_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2019.03.008","volume":"215","author":"J Purushotham","year":"2019","unstructured":"Purushotham J, Lambe T, Gilbert SC. Vaccine platforms for the prevention of Lassa fever. Immunol Lett. 2019;215:1\u201311. https:\/\/doi.org\/10.1016\/j.imlet.2019.03.008.","journal-title":"Immunol Lett"},{"issue":"5","key":"2008_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/trstmh\/traa011","volume":"114","author":"ND Kayem","year":"2020","unstructured":"Kayem ND, Benson C, Aye CYL, Barker S, Tome M, Kennedy S, et al. Lassa fever in pregnancy: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg. 2020;114(5):385\u201396. https:\/\/doi.org\/10.1093\/trstmh\/traa011.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"2008_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s40475-019-00194-x","volume":"6","author":"CB Krubiner","year":"2019","unstructured":"Krubiner CB, Schwartz DA. Viral hemorrhagic fevers in pregnant women and the vaccine landscape: comparisons between Yellow Fever, Ebola, and Lassa Fever. Current Tropical Medicine Reports. 2019;6(4):186\u201396. https:\/\/doi.org\/10.1007\/s40475-019-00194-x.","journal-title":"Current Tropical Medicine Reports"},{"key":"2008_CR23","unstructured":"Centers For Disease Control and Prevention. Signs and symptoms. 2014 [cited 2024 Jun 1]. https:\/\/www.cdc.gov\/vhf\/lassa\/symptoms\/index.html"},{"issue":"2","key":"2008_CR24","doi-asserted-by":"publisher","first-page":"e0006187","DOI":"10.1371\/journal.pntd.0006187","volume":"12","author":"EJ Mateer","year":"2018","unstructured":"Mateer EJ, Huang C, Shehu NY, Paessler S. Lassa fever-induced sensorineural hearing loss: a neglected public health and social burden. PLoS Negl Trop Dis. 2018;12(2):e0006187. https:\/\/doi.org\/10.1371\/journal.pntd.0006187.","journal-title":"PLoS Negl Trop Dis"},{"key":"2008_CR25","doi-asserted-by":"publisher","unstructured":"Adewole AA, Amode O, Gbejegbe EH, Musa AO, Adamu AN, Ojotule A, et al. Lassa fever in pregnancy: report of two maternal deaths in a tertiary center in the middle-belt region of Nigeria. Afr J Reprod Health. 2022;26(2):137\u201343. https:\/\/doi.org\/10.29063\/ajrh2022\/v26i2.13","DOI":"10.29063\/ajrh2022\/v26i2.13"},{"key":"2008_CR26","doi-asserted-by":"crossref","unstructured":"Price ME, Fisher-Hoch SP, Craven RB, McCormick JB. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ. 1988;297(6648):584\u20137. https:\/\/pubmed.ncbi.nlm.nih.gov\/3139220\/","DOI":"10.1136\/bmj.297.6648.584"},{"key":"2008_CR27","doi-asserted-by":"publisher","unstructured":"Voss G, Jacquet J-M, Tornieporth N, Kampmann B, Karron R, Meulen AS-T, et al. Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12\u201313 February 2020. Vaccine. 2021;39(51):7357\u201362. https:\/\/doi.org\/10.1016\/j.vaccine.2021.10.048","DOI":"10.1016\/j.vaccine.2021.10.048"},{"key":"2008_CR28","doi-asserted-by":"crossref","unstructured":"Beigi RH. Emerging infectious diseases in pregnancy. Obstet Gynecol. 2017;129(5):896\u2013906. https:\/\/europepmc.org\/article\/med\/28383378","DOI":"10.1097\/AOG.0000000000001978"},{"issue":"8","key":"2008_CR29","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3201\/eid2508.181299","volume":"25","author":"S Okogbenin","year":"2019","unstructured":"Okogbenin S, Okoeguale J, Akpede G, Colubri A, Barnes KG, Mehta S, et al. Retrospective cohort study of Lassa fever in pregnancy, southern Nigeria. Emerg Infect Dis. 2019;25(8):1494\u2013500. https:\/\/doi.org\/10.3201\/eid2508.181299.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"2008_CR30","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1016\/S2214-109X(20)30518-0","volume":"9","author":"A Duvignaud","year":"2021","unstructured":"Duvignaud A, Jaspard M, Etafo IC, Gabillard D, Serra B, Abejegah C, et al. Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study. Lancet Glob Health. 2021;9(4):e469\u201378. https:\/\/doi.org\/10.1016\/S2214-109X(20)30518-0.","journal-title":"Lancet Glob Health"},{"issue":"5","key":"2008_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/archdischild-2014-307861","volume":"101","author":"NE MacDermott","year":"2016","unstructured":"MacDermott NE, De S, Herberg JA. Viral haemorrhagic fever in children. Arch Dis Child. 2016;101(5):461\u20138. https:\/\/doi.org\/10.1136\/archdischild-2014-307861.","journal-title":"Arch Dis Child"},{"issue":"Pt 1","key":"2008_CR32","doi-asserted-by":"publisher","first-page":"126479","DOI":"10.1016\/j.vaccine.2024.126479","volume":"43","author":"M Chaudhary","year":"2024","unstructured":"Chaudhary M, Cutland CL, Bonet M, Gentile A, Jones CE, Marshall HS, et al. Burden of Lassa fever disease in pregnant women and children and options for prevention. Vaccine. 2024;43(Pt 1):126479. https:\/\/doi.org\/10.1016\/j.vaccine.2024.126479.","journal-title":"Vaccine"},{"issue":"2","key":"2008_CR33","doi-asserted-by":"publisher","first-page":"585","DOI":"10.4269\/ajtmh.20-0773","volume":"104","author":"RJ Samuels","year":"2020","unstructured":"Samuels RJ, Moon TD, Starnes JR, Alhasan F, Gbakie M, Goba A, et al. Lassa fever among children in Eastern Province, Sierra Leone: a 7-year retrospective analysis (2012\u20132018). Am J Trop Med Hyg. 2020;104(2):585\u201392. https:\/\/doi.org\/10.4269\/ajtmh.20-0773.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"2008_CR34","doi-asserted-by":"publisher","first-page":"408","DOI":"10.4269\/ajtmh.1987.36.408","volume":"36","author":"MH Monson","year":"1987","unstructured":"Monson MH, Cole AK, Frame JD, Serwint JR, Alexander S, Jahrling PB. Pediatric Lassa fever: a review of 33 Liberian cases. Am J Trop Med Hyg. 1987;36(2):408\u201315. https:\/\/doi.org\/10.4269\/ajtmh.1987.36.408.","journal-title":"Am J Trop Med Hyg"},{"issue":"8145","key":"2008_CR35","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/s0140-6736(79)90659-7","volume":"2","author":"MP Kiley","year":"1979","unstructured":"Kiley MP, Lange JV, Johnson KM. Protection of rhesus monkeys from Lassa virus by immunisation with closely related Arenavirus. Lancet. 1979;2(8145):738. https:\/\/doi.org\/10.1016\/s0140-6736(79)90659-7.","journal-title":"Lancet"},{"issue":"6","key":"2008_CR36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/tmi.13876","volume":"28","author":"G Sulis","year":"2023","unstructured":"Sulis G, Peebles A, Basta NE. Lassa fever vaccine candidates: a scoping review of vaccine clinical trials. Trop Med Int Health. 2023;28(6):420\u201331. https:\/\/doi.org\/10.1111\/tmi.13876.","journal-title":"Trop Med Int Health"},{"key":"2008_CR37","doi-asserted-by":"publisher","unstructured":"Isaac AB, Karolina W, Temitope AA, Anuska R, Joanne E, Deborah A, et al. Prospects of Lassa fever candidate vaccines. South Afr J Epidemiol Infect. 2022;16(2 Suppl):46\u201358. https:\/\/doi.org\/10.21010\/Ajid.v16i2S.6","DOI":"10.21010\/Ajid.v16i2S.6"},{"key":"2008_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.coviro.2019.07.006","volume":"37","author":"K Salami","year":"2019","unstructured":"Salami K, Gouglas D, Schmaljohn C, Saville M, Tornieporth N. A review of Lassa fever vaccine candidates. Curr Opin Virol. 2019;37:105\u201311. https:\/\/doi.org\/10.1016\/j.coviro.2019.07.006.","journal-title":"Curr Opin Virol"},{"issue":"10","key":"2008_CR39","doi-asserted-by":"publisher","first-page":"100960","DOI":"10.1016\/j.lanmic.2024.100960","volume":"5","author":"P Adepoju","year":"2024","unstructured":"Adepoju P. Lassa fever in Nigeria. Lancet. Microbe. 2024;5(10):100960. https:\/\/doi.org\/10.1016\/j.lanmic.2024.100960.","journal-title":"Microbe"},{"key":"2008_CR40","doi-asserted-by":"crossref","unstructured":"Ciapponi A, Berrueta M, Parker EPK, Bardach A, Mazzoni A, Anderson SA, et al. Safety of COVID-19 vaccines during pregnancy: a systematic review and meta-analysis. Vaccine. 2023;41(25):3688\u2013700. https:\/\/scholar.google.com\/citations?view_op=view_citation&hl=en&citation_for_view=ouR98K4AAAAJ:Y0pCki6q_DkC","DOI":"10.1016\/j.vaccine.2023.03.038"},{"key":"2008_CR41","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. Wiley; 2019. 736 p. https:\/\/play.google.com\/store\/books\/details?id=cTqyDwAAQBAJ","DOI":"10.1002\/9781119536604"},{"key":"2008_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jclinepi.2017.08.010","volume":"91","author":"JH Elliott","year":"2017","unstructured":"Elliott JH, Synnot A, Turner T, Simmonds M, Akl EA, McDonald S, et al. Living systematic review: 1. Introduction\u2014the why, what, when, and how. J Clin Epidemiol. 2017;91:23\u201330. https:\/\/doi.org\/10.1016\/j.jclinepi.2017.08.010.","journal-title":"J Clin Epidemiol"},{"key":"2008_CR43","unstructured":"World Health Organization. Regional Office for Europe. Guidance on an adapted evidence to recommendation process for National Immunization Technical Advisory Groups. World Health Organization. Regional Office for Europe; 2022 [cited 2023 Oct 21]. Report No.: WHO\/EURO:2022-5497-45262-64756. https:\/\/apps.who.int\/iris\/handle\/10665\/356896"},{"issue":"3","key":"2008_CR44","doi-asserted-by":"publisher","first-page":"e1003583","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18(3):e1003583. https:\/\/doi.org\/10.1371\/journal.pmed.1003583.","journal-title":"PLoS Med"},{"key":"2008_CR45","doi-asserted-by":"crossref","unstructured":"Kahale LA, Elkhoury R, El Mikati I, Pardo-Hernandez H, Khamis AM, Sch\u00fcnemann HJ, et al. Tailored PRISMA 2020 flow diagrams for living systematic reviews: a methodological survey and a proposal. F1000Res. 2021;10:192. https:\/\/f1000research.com\/articles\/10-192\/v2","DOI":"10.12688\/f1000research.51723.2"},{"key":"2008_CR46","doi-asserted-by":"publisher","unstructured":"Moher D, PRISMA-P Group, Shamseer L, Clarke M, Ghersi D, Liberati A, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4. https:\/\/doi.org\/10.1186\/2046-4053-4-1","DOI":"10.1186\/2046-4053-4-1"},{"issue":"49","key":"2008_CR47","doi-asserted-by":"publisher","first-page":"5993","DOI":"10.1016\/j.vaccine.2016.07.006","volume":"34","author":"J Bonhoeffer","year":"2016","unstructured":"Bonhoeffer J, Kochhar S, Hirschfeld S, Heath PT, Jones CE, Bauwens J, et al. Global alignment of immunization safety assessment in pregnancy\u2014the GAIA project. Vaccine. 2016;34(49):5993\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.006.","journal-title":"Vaccine"},{"key":"2008_CR48","unstructured":"Lassa fever\u2014SPEAC. SPEAC\u2014. SPEAC; 2023 [cited 2024 Oct 30]. https:\/\/speacsafety.net\/tools\/aesi-lists\/lassa-fever\/"},{"key":"2008_CR49","unstructured":"World Health Organization. Lassa Fever Outbreak Toolbox. 2022 [cited 2024 Oct 30]. https:\/\/cdn.who.int\/media\/docs\/default-source\/outbreak-toolkit\/final_lassa-fever-outbreak-toolbox_20221011.pdf?sfvrsn=d3852354_1#:~:text=WHO"},{"key":"2008_CR50","unstructured":"Risk of bias 2 (RoB 2) tool. [cited 2024 May 16]. https:\/\/methods.cochrane.org\/risk-bias-2"},{"key":"2008_CR51","unstructured":"[cited 2024 May 16]. https:\/\/methods.cochrane.org\/robins-i."},{"key":"2008_CR52","unstructured":"[cited 2024 May 16]. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"key":"2008_CR53","doi-asserted-by":"publisher","unstructured":"Ripley BD. The R project in statistical computing. MSOR Connect. 2001;1(1):23\u20135. https:\/\/doi.org\/10.11120\/msor.2001.01010023","DOI":"10.11120\/msor.2001.01010023"},{"key":"2008_CR54","doi-asserted-by":"crossref","unstructured":"Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1\u201348. https:\/\/www.jstatsoft.org\/article\/view\/v036i03","DOI":"10.18637\/jss.v036.i03"},{"key":"2008_CR55","doi-asserted-by":"publisher","unstructured":"Doi J, Potter G, Wong J, Alcaraz I, Chi P. Web application teaching tools for statistics using R and shiny. Technol Innov Stat Educ. 2016;9(1). https:\/\/doi.org\/10.5070\/t591027492","DOI":"10.5070\/t591027492"},{"issue":"9","key":"2008_CR56","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.rec.2021.07.010","volume":"74","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol. 2021;74(9):790\u20139. https:\/\/doi.org\/10.1016\/j.rec.2021.07.010.","journal-title":"Rev Esp Cardiol"}],"container-title":["Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-025-02008-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12978-025-02008-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-025-02008-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T07:12:37Z","timestamp":1744701157000},"score":1,"resource":{"primary":{"URL":"https:\/\/reproductive-health-journal.biomedcentral.com\/articles\/10.1186\/s12978-025-02008-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2008"],"URL":"https:\/\/doi.org\/10.1186\/s12978-025-02008-y","relation":{},"ISSN":["1742-4755"],"issn-type":[{"value":"1742-4755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval is not necessary for this systematic review and meta-analysis that utilizes published data or data in the public domain. The findings from the systematic review and living meta-analysis will be shared widely through the online dashboards mentioned earlier. Additionally, one or more manuscripts summarizing findings will be submitted to a prominent peer-reviewed journal in this area, following the PRISMA statement\/extension guidelines for reporting living systematic reviews.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study does not involve individual patient data or identifiable personal information requiring consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}